Indications and uses
How to Use: After using our toner, apply an appropriate amount to your entire face, and then gently pat your face to enhance its absorption into your skin.
SUPER AQUA MAX WHITE C CRYSTAL ESSENCE
- Manufacturer
- NATURE REPUBLIC CO., LTD.
- Effective date
- 2012-09-12
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:45:44
Label at a glance#
ProductSUPER AQUA MAX WHITE C CRYSTAL ESSENCE
Active ingredientGlycerin
Label structure8 sections
Dosage and administration
How to Use: After using our toner, apply an appropriate amount to your entire face, and then gently pat your face to enhance its absorption into your skin.
Label contents#
Full prescribing information#
ACTIVE INGREDIENT
Active Ingredient: Glycerin 20%
INACTIVE INGREDIENT
Inactive Ingredients:
Myrciaria Dubia Fruit Extract, Phenoxyethanol, Alcohol Denat., Butylene Glycol, Niacinamide, Pentylene Glycol, PEG-60 Hydrogenated Castor Oil, Carbomer, Arginine, Octyldodeceth-16, Fragrance(Parfum), Disodium EDTA, Sodium Hyaluronate, Water, Sodium Polyacrylate, Hedera Helix (Ivy) Leaf/Stem Extract, Phytic Acid, PEG-8, PPG-1-PEG-9 Lauryl Glycol Ether, Helianthus Annuus (Sunflower) Seed Extract, Trichosanthes Kirilowii Root Extract, Oenothera Biennis (Evening Primrose) Flower Extract, Ipomoea Purpurea Extract, Mirabilis Jalapa Extract, Citrus Aurantium Dulcis (Orange) Fruit Water, Avena Sativa (Oat) Kernel Extract, Rubus Idaeus (Raspberry) Leaf Extract, Calendula Officinalis Flower Extract, Nepeta Cataria Extract, Stellaria Media (Chickweed) Extract, Baptisia Tinctoria Root Extract, Ascorbyl Glucoside
PURPOSE
Purpose: Highly moisturizing radiant brigtening essence
WARNINGS
Cautions:
For external use only.
Avoid contact with eyes and mouth.
Discontinue use if signs of irritation or rash appear.
Keep out of reach of children.
Replace the cap after use.
KEEP OUT OF REACH OF CHILDREN
KEEP OUT OF REACH OF CHILDREN
INDICATIONS AND USAGE
How to Use: After using our toner, apply an appropriate amount to your entire face, and then gently pat your face to enhance its absorption into your skin.
DOSAGE AND ADMINISTRATION
How to Use: After using our toner, apply an appropriate amount to your entire face, and then gently pat your face to enhance its absorption into your skin.
PACKAGE LABEL. PRINCIPAL DISPLAY PANEL
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 8809344263827 | GTIN-13: 8809344263827 EAN-13: 8809344263827 GTIN storage (14 digits): 08809344263827 | super aqua max white c crystal essence carton.jpg |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51346-129-01 | 2021-06-30 | C162847 | 48780-1 | 9d75b9d0-03d0-f424-e053-dadaa90a57ce | cf867ef6-b0a2-40db-ae91-724e226c0c25 |
| 51346-129-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-03d0-f424-e053-dadaa90a57ce | cf867ef6-b0a2-40db-ae91-724e226c0c25 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Glycerin | ACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Glycerin | ACTIVE MOIETY | PDC6A3C0OX | 1 | |
| Arginine | INACTIVE INGREDIENT | 94ZLA3W45F | 1 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| Niacinamide | INACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| Pentylene Glycol | INACTIVE INGREDIENT | 50C1307PZG | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 |
Products#
Every source-derived product name is available through these pages.
- SUPER AQUA MAX WHITE C CRYSTAL ESSENCE
- Glycerin
- Phenoxyethanol
- Butylene Glycol
- Niacinamide
- Pentylene Glycol
- Arginine
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 51346-129 | 51346-129-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Glycerin | PDC6A3C0OX | ACTIM |
| Phenoxyethanol | HIE492ZZ3T | IACT |
| Butylene Glycol | 3XUS85K0RA | IACT |
| Niacinamide | 25X51I8RD4 | IACT |
| Pentylene Glycol | 50C1307PZG | IACT |
| Arginine | 94ZLA3W45F | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAVENOUS | 2.5 %w/v | ||
| Arginine | ARGININE | 94ZLA3W45F | TABLET, FILM COATED / ORAL | 25 mg | ||
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| Arginine | ARGININE | 94ZLA3W45F | INJECTION / INTRAMUSCULAR | NA | ||
| Arginine | ARGININE | 94ZLA3W45F | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 3600 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| Arginine | ARGININE | 94ZLA3W45F | TABLET, EXTENDED RELEASE / ORAL | 20 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| Arginine | ARGININE | 94ZLA3W45F | POWDER, FOR SOLUTION / INTRAVENOUS | 7.07 %w/v | ||
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| Arginine | ARGININE | 94ZLA3W45F | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 6240 mg | ||
| Arginine | ARGININE | 94ZLA3W45F | INJECTION, SOLUTION / INTRAVENOUS | 0.29 %w/v | ||
| Arginine | ARGININE | 94ZLA3W45F | INJECTION / INTRAVENOUS | 790 mg | ||
| Arginine | ARGININE | 94ZLA3W45F | TABLET / ORAL | 50 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| Arginine | ARGININE | 94ZLA3W45F | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | ADJ PH | ||
| Arginine | ARGININE | 94ZLA3W45F | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 6240 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAMUSCULAR | 2.5 %w/v | ||
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | CREAM / TOPICAL | NA | ||
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | GEL / TOPICAL | 25 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 80d793ef-5970-4537-aed9-f32c073d3087 | cf867ef6-b0a2-40db-ae91-724e226c0c25 | 2021-06-29 | Warnings | cf867ef6-b0a2-40db-ae91-724e226c0c25 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.